Research graph
References from Hormone therapy potentiates chemoimmunotherapy by inducing SUMOylation-mediated immunogenic cell death. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41423-020-0488-6
10.1038/s41423-020-0488-6 · External reference
Current and future immunotherapy for breast cancer
10.1186/s13045-024-01649-z · 2024 · External reference
10.1200/jco.2015.64.8931
10.1200/jco.2015.64.8931 · External reference
Immunological profiles of the breast cancer microenvironment represented by tumor-infiltrating lymphocytes and PD-L1 expression
10.1038/s41598-022-11578-x · 2022 · External reference
10.1016/j.annonc.2023.10.011
10.1016/j.annonc.2023.10.011 · External reference
10.1016/j.annonc.2023.10.010
10.1016/j.annonc.2023.10.010 · External reference
10.1038/s41591-024-03415-7
10.1038/s41591-024-03415-7 · External reference
Hormone therapy enhances anti-PD1 efficacy in premenopausal estrogen receptor-positive and HER2-negative advanced breast cancer
10.1016/j.xcrm.2024.101879 · 2025 · External reference
10.1038/s41573-018-0007-y
10.1038/s41573-018-0007-y · External reference
10.1038/s41568-021-00347-z
10.1038/s41568-021-00347-z · External reference
Cold and hot tumors: from molecular mechanisms to targeted therapy
10.1038/s41392-024-01979-x · 2024 · External reference
10.1056/nejmoa1801005
10.1056/nejmoa1801005 · External reference
10.21203/rs.3.rs-3290264/v1
10.21203/rs.3.rs-3290264/v1 · External reference
10.1210/me.2004-0486
10.1210/me.2004-0486 · External reference
Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
10.1080/2162402x.2019.1703449 · 2020 · External reference
10.1038/s41573-024-00920-9
10.1038/s41573-024-00920-9 · External reference
10.1084/jem.20050915
10.1084/jem.20050915 · External reference
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
10.1136/jitc-2019-000337 · 2020 · External reference
10.1146/annurev-immunol-032712-100008
10.1146/annurev-immunol-032712-100008 · External reference
10.1038/s41590-022-01132-2
10.1038/s41590-022-01132-2 · External reference
Immunogenic cell death in cancer: concept and therapeutic implications
10.1186/s12967-023-04017-6 · 2023 · External reference
Detection of immunogenic cell death and its relevance for cancer therapy
10.1038/s41419-020-03221-2 · 2020 · External reference
10.1158/2159-8290.cd-20-1209
10.1158/2159-8290.cd-20-1209 · External reference
10.1038/s41416-023-02181-6
10.1038/s41416-023-02181-6 · External reference
Modeling T cell temporal response to cancer immunotherapy rationalizes development of combinatorial treatment protocols
10.1038/s43018-024-00734-z · 2024 · External reference
10.1016/s0140-6736(05)66546-4
10.1016/s0140-6736(05)66546-4 · External reference
10.1038/nrclinonc.2015.99
10.1038/nrclinonc.2015.99 · External reference
MAP3K1 mutations confer tumor immune heterogeneity in hormone receptor-positive HER2-negative breast cancer
10.1172/jci183656 · 2024 · External reference
10.1158/1078-0432.ccr-07-4491
10.1158/1078-0432.ccr-07-4491 · External reference
10.1016/j.ccell.2015.10.012
10.1016/j.ccell.2015.10.012 · External reference
10.1038/nm1523
10.1038/nm1523 · External reference
Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
10.1001/jamaoncol.2017.2085 · 2017 · External reference
10.1038/nrc3258
10.1038/nrc3258 · External reference
10.1146/annurev-immunol-100311-102839
10.1146/annurev-immunol-100311-102839 · External reference
10.1038/nm1622
10.1038/nm1622 · External reference
10.1038/nrm2617
10.1038/nrm2617 · External reference
10.1038/nature10098
10.1038/nature10098 · External reference
10.1016/j.immuni.2016.06.020
10.1016/j.immuni.2016.06.020 · External reference
10.1084/jem.20070247
10.1084/jem.20070247 · External reference
10.1038/cr.2017.133
10.1038/cr.2017.133 · External reference
10.1038/s12276-022-00736-w
10.1038/s12276-022-00736-w · External reference
10.1016/j.tibs.2025.09.003
10.1016/j.tibs.2025.09.003 · External reference
10.1056/nejmoa1910549
10.1056/nejmoa1910549 · External reference
10.1158/0008-5472.can-20-1705
10.1158/0008-5472.can-20-1705 · External reference
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
10.1186/s12935-021-02003-w · 2021 · External reference
Nidogen-1 Mitigates Ischemia and Promotes Tissue Survival and Regeneration
10.1002/advs.202002500 · 2021 · External reference
Tumor Cell-Intrinsic CD96 Mediates Chemoresistance and Cancer Stemness by Regulating Mitochondrial Fatty Acid β-Oxidation
10.1002/advs.202202956 · 2023 · External reference
Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity
10.1038/s43018-022-00352-7 · 2022 · External reference
